Related Experiment Video
Updated: May 21, 2026

"Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection
Published on: February 19, 2019
Increased interleukin-32 expression in chronic hepatitis B virus-infected liver
Qihuan Xu1, Xingfei Pan, Xin Shu
1Department of Infectious Diseases, The 3rd Affiliated Hospital, Sun Yat-Sen University, No.600, Tianhe Road, Guangzhou 510630, China.
Interleukin-32 (IL-32) expression is elevated in chronic hepatitis B (CHB) patients, correlating with liver inflammation and fibrosis severity. This suggests IL-32 plays a role in the disease
Area of Science:
- Hepatology
- Immunology
- Molecular Biology
Background:
- The role of interleukin-32 (IL-32) in chronic hepatitis B (CHB) pathogenesis is not well understood.
- IL-32 is a cytokine with diverse roles in inflammation and immunity.
Purpose of the Study:
- To investigate the expression levels of IL-32 in liver tissues of CHB patients.
- To analyze the correlation between IL-32 expression and the severity of liver inflammation and fibrosis in CHB.
Main Methods:
- Real-time PCR and immunohistochemistry were employed to quantify IL-32 expression in liver samples.
- Spearman's correlation analysis was used to assess the relationship between IL-32 levels and clinicopathological features.
Main Results:
- Hepatic IL-32 expression was significantly upregulated in CHB patients compared to controls.
- IL-32 expression levels positively correlated with the severity of liver inflammation and fibrosis.
- IL-32 expression showed a significant positive correlation with serum ALT levels and a negative correlation with serum ALB levels.
Conclusions:
- Interleukin-32 (IL-32) is implicated in the inflammatory and fibrotic processes of chronic hepatitis B (CHB).
- IL-32 may represent a potential therapeutic target or biomarker for CHB.
More Related Videos
Related Concept Videos
Hepatitis
Cirrhosis II: Pathophysiology
Viral Hepatitis I: Introduction
Inflammatory Bowel Disease III: Crohn's Disease
Inflammatory Bowel Disease II: Ulcerative Colitis
Inhibitors of Viral Protein Synthesis

